Compositions for delivery of therapeutics into the eyes and methods for making and using same

Details for Australian Patent Application No. 2004263149 (hide)

Owner Allergan, Inc.

Inventors Graham, Richard; Vehige, Joseph G.; Chang, Chin-Ming; Kuan, Teresa H.; Chang, James N.; Lyons, Robert T.

Agent Davies Collison Cave

Pub. Number AU-B-2004263149

PCT Pub. Number WO2005/014046

Priority 60/493,188 07.08.03 US; 60/493,178 07.08.03 US

Filing date 5 August 2004

Wipo publication date 17 February 2005

Acceptance publication date 19 August 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014046 Priority application(s): WO2005/014046

19 August 2010 Application Accepted

  Published as AU-B-2004263149

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263152-Systems and methods for performing dynamic pedicle integrity assessments

2004263148-Aminotriazole compounds useful as inhibitors of protein kinases